These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11459433)

  • 1. Vascular adhesion molecule-1 and markers of platelet function before and after a treatment with iloprost or a supervised physical exercise program in patients with peripheral arterial disease.
    Arosio E; Minuz P; Prior M; Zuliani V; Gaino S; De Marchi S; Fontana L; Andrioli G; Lechi C; Lechi A
    Life Sci; 2001 Jun; 69(4):421-33. PubMed ID: 11459433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1.
    Cozzolino D; Coppola L; Masi S; Salvatore T; Sasso FC; De Lucia D; Gentile S; Torella R
    Eur J Clin Pharmacol; 1999 Sep; 55(7):491-7. PubMed ID: 10501817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of iloprost on plasma asymmetric dimethylarginine and plasma and platelet serotonin in patients with peripheral arterial occlusive disease.
    Blardi P; de Lalla A; Pieragalli D; De Franco V; Meini S; Ceccatelli L; Auteri A
    Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):175-82. PubMed ID: 16939882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost.
    Lessiani G; Vazzana N; Cuccurullo C; Di Michele D; Laurora G; Sgrò G; Di Ruscio P; Simeone E; Di Iorio P; Lattanzio S; Liani R; Ferrante E; Davì G
    Thromb Haemost; 2011 Feb; 105(2):321-8. PubMed ID: 21103664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in circulating endothelial cell adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: preliminary results.
    Boehme MW; Gao IK; Norden C; Lemmel EM
    Rheumatol Int; 2006 Feb; 26(4):340-7. PubMed ID: 15700117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased endogenous nitric oxide production induced by physical exercise in peripheral arterial occlusive disease patients.
    Arosio E; Cuzzolin L; De Marchi S; Minuz P; Degan M; Crivellente F; Zannoni M; Benoni G
    Life Sci; 1999; 65(26):2815-22. PubMed ID: 10622270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
    Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive disease.
    Tsakiris DA; Tschöpl M; Wolf F; Labs KH; Jäger KA; Marbet GA
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):165-73. PubMed ID: 10759010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
    Ciuffetti G; Sokola E; Lombardini R; Pasqualini L; Pirro M; Mannarino E
    Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy controls.
    Reininger AJ; Agneskirchner J; Bode PA; Spannagl M; Wurzinger LJ
    Thromb Haemost; 2000 Feb; 83(2):217-23. PubMed ID: 10739376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supervised exercise training reduces plasma levels of the endothelial inflammatory markers E-selectin and ICAM-I in patients with peripheral arterial disease.
    Saetre T; Enoksen E; Lyberg T; Stranden E; Jørgensen JJ; Sundhagen JO; Hisdal J
    Angiology; 2011 May; 62(4):301-5. PubMed ID: 21474466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of iloprost on adhesion molecules and F1 + 2 in peripheral ischemia.
    Mazzone A; Faggioli P; Cusa C; Stefanin C; Rondena M; Morelli B
    Eur J Clin Invest; 2002 Dec; 32(12):882-8. PubMed ID: 12534446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization.
    Coppolino G; Buemi A; Bolignano D; Lacquaniti A; La Spada M; Stilo F; De Caridi G; Benedetto F; Loddo S; Buemi M; Spinelli F
    J Surg Res; 2009 Nov; 157(1):e129-35. PubMed ID: 19589539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels.
    Mittag M; Beckheinrich P; Haustein UF
    Acta Derm Venereol; 2001; 81(4):294-7. PubMed ID: 11720181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease.
    Gianetti J; De Caterina M; De Cristofaro T; Ungaro B; Guercio RD; De Caterina R
    Am Heart J; 2001 Oct; 142(4):733-9. PubMed ID: 11579367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
    Arosio E; Sardina M; Prior M; De Marchi S; Zannoni M; Bianchini C
    Eur Rev Med Pharmacol Sci; 1998; 2(2):53-9. PubMed ID: 10229559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of a stable prostacyclin analogue, iloprost, to patients with peripheral vascular disease: lack of antiplatelet effect but risk of thromboembolism.
    Kovacs IB; Mayou SC; Kirby JD
    Am J Med; 1991 Jan; 90(1):41-6. PubMed ID: 1702580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test.
    Signorelli SS; Mazzarino MC; Di Pino L; Malaponte G; Porto C; Pennisi G; Marchese G; Costa MP; Digrandi D; Celotta G; Virgilio V
    Vasc Med; 2003; 8(1):15-9. PubMed ID: 12866607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iloprost reduces procoagulant activity in the extracorporeal circuit.
    Korn RL; Fisher CA; Stenach N; Jeevanandam V; Addonizio VP
    J Surg Res; 1993 Oct; 55(4):433-40. PubMed ID: 7692141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Soluble cell adhesion molecules in chronic renal graft rejection].
    Boratyńska M
    Pol Arch Med Wewn; 1998 Nov; 100(5):410-8. PubMed ID: 10410574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.